# Decision Record — Gate 2 (End of Phase 4 → Phase 5)

**Date:** 2026-09-06
**Gate:** Gate 2 — End of Phase 4, per `PROJECT_AI_PROTOCOL.md` §21
**Review request:** `00_PROJECT_CONTROL/CHATGPT_REVIEW_REQUEST.md` (Gate 2 version, now superseded by
this record and reset to "no gate open" — see §4 below)
**Decided by:** Human (relaying ChatGPT/human review)
**Recorded by:** Claude Code, at the human's explicit instruction

---

## 1. Decision — Gate 2 itself

**GO.**

Phase 4 (Curriculum ↔ Decision Integration) is approved to close as-is. Both artifacts
(`KNOWLEDGE_DECISION_DEPTH_MAP.md`, `DECISION_KNOWLEDGE_READINESS.md`), their cross-validation, and the
self-audit performed before the Gate request was prepared are accepted as sufficient. No further Phase 4
work is requested.

**Effect:**
- Phase 4 status: artifacts-complete → `CLOSED`.
- Phase 5 (Evidence & Knowledge Expansion): authorized to begin, in this same session per explicit
  instruction (§6 of the human's message) — unlike Gate 1, this is not deferred to a future session.
- None of the two Phase 4 artifacts, nor any Phase 3 artifact, was modified by this decision.

## 2. Decision on the three flagged bookkeeping discrepancies

**Deferred — not blocking, not resolved, not reinterpreted.**

1. `CLINICAL_NUTRITION_ARCHITECTURE.md` Layer-5 count (states 23/13, enumeration implies 24/14).
2. `APP_DECISION_KNOWLEDGE_MAPPING.md` §8b/§20 Level-2 subtopic undercount (omits `NUT-04.01–.03`).
3. `APP_DECISION_KNOWLEDGE_MAPPING.md` §5-vs-§8a strength mismatch (`NUT-01`/`DEC-002`: `CORE` vs
   `CONTEXTUAL`).

All three remain explicitly documented findings, not silently resolved. Per the human's explicit
instruction: if a Phase 5 task naturally requires one of these records for downstream consistency, the
smallest necessary correction may be made *only if the protocol permits it* (per `PROJECT_AI_PROTOCOL.md`
§36's change discipline — determine why it must change, whether it's within the current phase, what
downstream documents depend on it, whether stable IDs are affected, whether revalidation is required, and
flag as `UPSTREAM CHANGE` if so); otherwise, flag without blocking unrelated work. No such correction has
been made as of this record — see §5 below for Phase 5's own posture on these three items.

## 3. `DEC-099`/`DEC-100` — reaffirmed unresolved

Per explicit instruction, `DEC-099`/`DEC-100`'s clinical/scope status remains exactly as unresolved as at
Gate 1. Phase 5 must not resolve them; Phase 5's own worklist (§5 below) explicitly excludes them from
its clinical-evidence scope for that reason.

## 4. Control-state files updated

Per explicit instruction (§5 of the human's message):
- `00_PROJECT_CONTROL/PROJECT_STATUS.md` — Phase 4 marked `CLOSED`; Phase 5 marked `STARTED`.
- `00_PROJECT_CONTROL/AI_SESSION_STATE.md` — updated to reflect Gate 2's resolution and Phase 5's start.
- `00_PROJECT_CONTROL/CHATGPT_REVIEW_REQUEST.md` — reset to a "no gate currently open" placeholder, per
  `PROJECT_AI_PROTOCOL.md` §48.2's own framing of that file as present only while a gate is open. Its
  Gate 2 content is fully preserved in this record; nothing is lost.
- This file itself, newly created — the second entry in `00_PROJECT_CONTROL/DECISIONS/`.

## 5. What happens next

Per explicit instruction, Phase 5 begins **in this same session**, autonomously, per
`PROJECT_AI_PROTOCOL.md` §13. Phase 5's starting worklist is not invented fresh — it reuses the
evidence-dependent items already isolated by Phase 3/4 (the `CONDITIONAL`-tiered topics and
current-evidence-primary decisions) plus Phase 1/2's own previously-deferred currency items. See
`AI_SESSION_STATE.md`'s "Exact Next Action" for the concrete starting point. Ordinary Phase 5 workflow
choices (which artifact to produce, how to organize the evidence-question register, etc.) are resolved
autonomously per explicit instruction — none of these is treated as a Review Gate.
